Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Stanek
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Stanek 100mg/25mg/200mg tablets
0409010X0BDAFAB
|
Stanek | Levodopa/carbidopa/entacapone | Central Nervous System | 1,686 |
|
Stanek 150mg/37.5mg/200mg tablets
0409010X0BDADAC
|
Stanek | Levodopa/carbidopa/entacapone | Central Nervous System | 1,280 |
|
Stanek 125mg/31.25mg/200mg tablets
0409010X0BDAGAF
|
Stanek | Levodopa/carbidopa/entacapone | Central Nervous System | 1,262 |
|
Stanek 200mg/50mg/200mg tablets
0409010X0BDABAD
|
Stanek | Levodopa/carbidopa/entacapone | Central Nervous System | 778 |
|
Stanek 75mg/18.75mg/200mg tablets
0409010X0BDAAAE
|
Stanek | Levodopa/carbidopa/entacapone | Central Nervous System | 455 |
|
Stanek 175mg/43.75mg/200mg tablets
0409010X0BDACAG
|
Stanek | Levodopa/carbidopa/entacapone | Central Nervous System | 445 |
|
Stanek 50mg/12.5mg/200mg tablets
0409010X0BDAEAA
|
Stanek | Levodopa/carbidopa/entacapone | Central Nervous System | 215 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.